TGF-beta1 gene silencing for treating liver fibrosis.
TGF-beta1 gene silencing for treating liver fibrosis.
复制标题
DOI:
10.1021/mp9000469
复制
发表时间:
2009-05
影响因子:
4.9
通讯作者:
Mahato RI
中科院分区:
文献类型:
--
作者:
Cheng K;Yang N;Mahato RI
Small interfering RNA (siRNA) and short hairpin RNA (shRNA) targeting different regions of transforming growth factor β1 (TGF-β1) mRNA were designed and the silencing effect was determined after transfection into immortalized rat liver stellate cells (HSC-T6). There was not only significant decrease in TGF-β1, tissue inhibitor of metalloproteinase 1 (TIMP-1), α-smooth muscle actin (α-SMA) and type I collagen after transfection with TGF-β1 siRNAs, but also synergism in gene silencing when siRNAs targeting two different start sites were used as a pool for transfection. The two siRNA sequences which efficiently inhibited TGF-β1 gene expression were converted to shRNAs via cloning into the pSilencer1.0. There was significant decrease in TGF-β1 and TIMP-1 when HSC-T6 cells were transfected with pshRNA targeting the same regions of TGF-β1 mRNA as siRNAs. Furthermore, TGF-β1 gene silencing in HSC-T6 cells significantly decreased the levels of inflammatory cykokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β). In conclusion, both siRNA and shRNA showed sequence-specific and dose dependent TGF-β1 gene silencing, and has the potential to treat liver fibrosis.
登录
查看更多内容
影响因子:
4.7
作者:
Zhu L;Lu Y;Miller DD;Mahato RI
通讯作者:
Mahato RI
DOI:
10.1016/j.bbrc.2006.03.087
发表时间:
2006-05-19
影响因子:
3.1
作者:
Kim, KH;Kim, HC;Park, KK
通讯作者:
Park, KK
DOI:
10.1097/00042737-200402000-00001
发表时间:
2004-02-01
影响因子:
2.1
作者:
Shek, FW;Benyon, RC
通讯作者:
Benyon, RC
DOI:
10.1073/pnas.96.22.12719
发表时间:
1999-10-26
影响因子:
11.1
作者:
George, J;Roulot, D;Bissell, DM
通讯作者:
Bissell, DM
DOI:
10.1073/pnas.96.5.2345
发表时间:
1999-03-02
影响因子:
11.1
作者:
Qi, Z;Atsuchi, N;Ueno, H
通讯作者:
Ueno, H